Surgical Science Sweden AB (publ) (SUSRF)

OTCMKTS · Delayed Price · Currency is USD
15.10
-1.23 (-7.53%)
At close: Jun 13, 2025
8.24%
Market Cap 813.09M
Revenue (ttm) 94.30M
Net Income (ttm) 14.06M
Shares Out n/a
EPS (ttm) 0.27
PE Ratio 57.85
Forward PE 32.56
Dividend n/a
Ex-Dividend Date n/a
Volume 3,000
Average Volume 2,124
Open 15.10
Previous Close 16.33
Day's Range 15.10 - 15.10
52-Week Range 11.30 - 16.33
Beta 0.63
RSI 54.43
Earnings Date Aug 21, 2025

About SUSRF

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra... [Read more]

Sector Healthcare
Founded 1997
Employees 274
Stock Exchange OTCMKTS
Ticker Symbol SUSRF
Full Company Profile

Financial Performance

In 2024, SUSRF's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.